CXCL10 and ovarian cancer: A previous study reported that CSF1 blockade in ovarian cancer models resulted in a significant reduction in CD163+ M2-like TAMs, with a concomitant increase in M1-polarized macrophages producing CXCL10, a chemokine crucial for T-cell recruitment.